ATC Group: B02AB05 Ulinastatin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of B02AB05 in the ATC hierarchy

Level Code Title
1 B Blood and blood forming organs
2 B02 Antihemorrhagics
3 B02A Antifibrinolytics
4 B02AB Proteinase inhibitors
5 B02AB05

Active ingredients in B02AB05

Active Ingredient Description
Ulinastatin

Ulinastatin is a serine protease inhibitor that reduces the pro-inflammatory response as a result of sepsis, acute pancreatitis, trauma or surgery. It inhibits coagulation and fibrinolysis and promotes microperfusion. Thus, ulinastatin is an effective agent for immune modulation to prevent organ dysfunction and promote homeostasis.

Medicines in this ATC group

Japan (JP)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.